- Home
- EPIX
EPIX
ESSA Pharma Inc.
as 04-18-2025 1:35pm EST
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
| Founded: | 2009 | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 65.3M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 186.2K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.40 - $7.88 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ESSA Pharma Inc. News
EPIX Breaking Stock News: Dive into EPIX Ticker-Specific Updates for Smart Investing
Simply Wall St.
18 days ago
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
CNW Group
a month ago
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Simply Wall St.
2 months ago
February 2025's Top US Penny Stocks To Consider
Associated Press Finance
2 months ago
ESSA Pharma: Fiscal Q1 Earnings Snapshot
CNW Group
2 months ago
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024
Simply Wall St.
4 months ago
3 Promising US Penny Stocks With Market Caps Under $80M
Simply Wall St.
4 months ago
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit?
Associated Press Finance
4 months ago
ESSA Pharma: Fiscal Q4 Earnings Snapshot
Compare EPIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EPIX ESSA Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.